IRIS Accounts Production v26.2.0.496 06406479 Board of Directors 1.1.25 31.12.25 31.12.25 false true true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064064792024-12-31064064792025-12-31064064792025-01-012025-12-31064064792023-12-31064064792024-01-012024-12-31064064792024-12-3106406479ns15:EnglandWales2025-01-012025-12-3106406479ns14:PoundSterling2025-01-012025-12-3106406479ns10:Director12025-01-012025-12-3106406479ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3106406479ns10:SmallEntities2025-01-012025-12-3106406479ns10:Audited2025-01-012025-12-3106406479ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3106406479ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3106406479ns10:FullAccounts2025-01-012025-12-3106406479ns10:OrdinaryShareClass12025-01-012025-12-3106406479ns10:Director22025-01-012025-12-3106406479ns10:Director32025-01-012025-12-3106406479ns10:CompanySecretary12025-01-012025-12-3106406479ns10:RegisteredOffice2025-01-012025-12-3106406479ns5:CurrentFinancialInstruments2025-12-3106406479ns5:CurrentFinancialInstruments2024-12-3106406479ns5:ShareCapital2025-12-3106406479ns5:ShareCapital2024-12-3106406479ns5:RetainedEarningsAccumulatedLosses2025-12-3106406479ns5:RetainedEarningsAccumulatedLosses2024-12-3106406479ns5:PlantMachinery2025-01-012025-12-3106406479ns5:FurnitureFittings2025-01-012025-12-3106406479ns5:ComputerEquipment2025-01-012025-12-3106406479ns5:OwnedAssets2025-01-012025-12-3106406479ns5:OwnedAssets2024-01-012024-12-3106406479ns5:PlantMachinery2024-12-3106406479ns5:FurnitureFittings2024-12-3106406479ns5:ComputerEquipment2024-12-3106406479ns5:PlantMachinery2025-12-3106406479ns5:FurnitureFittings2025-12-3106406479ns5:ComputerEquipment2025-12-3106406479ns5:PlantMachinery2024-12-3106406479ns5:FurnitureFittings2024-12-3106406479ns5:ComputerEquipment2024-12-3106406479ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3106406479ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106406479ns10:OrdinaryShareClass12025-12-31
REGISTERED NUMBER: 06406479 (England and Wales)















LYNTON CLINICS LIMITED

REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025






LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025










Page

Company Information 1

Report of the Directors 2

Report of the Independent Auditors 4

Income Statement 8

Balance Sheet 9

Notes to the Financial Statements 10


LYNTON CLINICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTORS: J A Exley PhD
Dr A Charlton D.Phil
A J Berry PhD





SECRETARY: A J Berry PhD





REGISTERED OFFICE: Lynton House
Manor Lane
Holmes Chapel
Cheshire
CW4 8AF





REGISTERED NUMBER: 06406479 (England and Wales)





AUDITORS: Clarke Nicklin LLP
Chartered Accountants and
Statutory Auditors
Clarke Nicklin House
Brooks Drive
Cheadle Royal Business Park
Cheadle
Cheshire
SK8 3TD

LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2025


The directors present their report with the financial statements of the company for the year ended 31 December 2025.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of the provision of beauty related services, with an emphasis on the field of dermatology and cosmetic applications.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report.

J A Exley PhD
Dr A Charlton D.Phil
A J Berry PhD

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Clarke Nicklin LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.


LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2025

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





J A Exley PhD - Director


10 September 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
LYNTON CLINICS LIMITED


Opinion
We have audited the financial statements of Lynton Clinics Limited (the 'company') for the year ended 31 December 2025 which comprise the Income Statement, Balance Sheet and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Report of the Directors has been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
LYNTON CLINICS LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit; or
- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Directors.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page two, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
LYNTON CLINICS LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Procedures to identify risks:
- enquiring of management concerning the company's procedures relating to: identifying, evaluating and
complying with laws and regulations and whether they were aware of any instances of noncompliance;
detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected
or alleged fraud;
- discussing among the engagement team regarding how and where fraud might occur in the financial
statements and any potential indicators of fraud. As part of this discussion, we identified potential for fraud
in the following areas: timing of recognition of sales and purchases and their related stock movements,
posting of unusual journals; and
- obtaining an understanding of the legal and regulatory frameworks that the company operates in, focusing
on those laws and regulations that had a direct effect on the financial statements or that had a
fundamental effect on the operations of the company. The key laws and regulations we considered in this
context included UK Companies Act, employment law, health and safety, pensions legislation and tax
legislation.

The procedures to respond to risks identified included:
- reviewing the financial statement disclosures and testing to supporting documentation to assess
compliance with relevant laws and regulations discussed above;
- enquiring of management, concerning actual and potential litigation and claims;
- performing analytical procedures to identify any unusual or unexpected relationships that may indicate
risks of material misstatement due to fraud;
- reviewing correspondence with HMRC;
- testing the timing and matching of income and expense transactions; and
- in addressing the risk of fraud through management override of controls, testing the appropriateness of
journal entries and other adjustments; assessing whether the judgements made in making accounting
estimates are indicative of a potential bias; and evaluating the business rationale of any significant
transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulation that are not closely related to events and transactions reflected in the financial statements. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from an error, as fraud may involve deliberate concealment, by for example, forgery or intentional misrepresentation, or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
LYNTON CLINICS LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Kerry Burr FCA (Senior Statutory Auditor)
for and on behalf of Clarke Nicklin LLP
Chartered Accountants and
Statutory Auditors
Clarke Nicklin House
Brooks Drive
Cheadle Royal Business Park
Cheadle
Cheshire
SK8 3TD

10 September 2026

LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   

TURNOVER 137,841 113,113

Cost of sales 20,706 18,966
GROSS PROFIT 117,135 94,147

Administrative expenses 94,968 102,187
OPERATING PROFIT/(LOSS) and
PROFIT/(LOSS) BEFORE TAXATION 22,167 (8,040 )

Tax on profit/(loss) 2,027 (3,501 )
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR

20,140

(4,539

)

LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 23,975 32,195

CURRENT ASSETS
Debtors 6 213,971 163,001
Cash at bank and in hand 119,815 120,293
333,786 283,294
CREDITORS
Amounts falling due within one year 7 281,295 259,699
NET CURRENT ASSETS 52,491 23,595
TOTAL ASSETS LESS CURRENT
LIABILITIES

76,466

55,790

PROVISIONS FOR LIABILITIES 1,079 543
NET ASSETS 75,387 55,247

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 75,287 55,147
SHAREHOLDERS' FUNDS 75,387 55,247

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2026 and were signed on its behalf by:





J A Exley PhD - Director


LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025


1. STATUTORY INFORMATION

Lynton Clinics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in Sterling (£).

Going concern
The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have reached this conclusion giving due consideration to the projected future performance of the company and any potential risk that might impact the company's ability to meet its required solvency levels. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Significant judgements and estimates
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if revision only affects that period, or in the period of the revision and future periods if the revision affects both current and future periods.

The following judgements have had the most significant effect on amounts recognised in the financial statements:

Depreciation
The useful life of fixed assets can vary significantly. Estimates are based on historic experience and current expectations of useful life. The size of prior year gains and losses on disposal are also factored in to estimates.

Bad debts
The directors regularly review debts and provide for those which are doubtful.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax. Sales are recognised on either date of sale or the date that any treatments were carried out, except in respect of service contracts where sales are recognised when the company obtains the right to consideration.

LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025


2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Clinic equipment - 25% on cost
Fixtures and fittings - 25% on cost
Office equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4. OPERATING PROFIT/(LOSS)

The operating profit (2024 - operating loss) is stated after charging:

2025 2024
£    £   
Depreciation - owned assets 8,220 7,257

LYNTON CLINICS LIMITED (REGISTERED NUMBER: 06406479)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025


5. TANGIBLE FIXED ASSETS
Fixtures
Clinic and Office
equipment fittings equipment Totals
£    £    £    £   
COST
At 1 January 2025
and 31 December 2025 148,261 419 14,161 162,841
DEPRECIATION
At 1 January 2025 116,066 419 14,161 130,646
Charge for year 8,220 - - 8,220
At 31 December 2025 124,286 419 14,161 138,866
NET BOOK VALUE
At 31 December 2025 23,975 - - 23,975
At 31 December 2024 32,195 - - 32,195

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 14,497 9,583
Amounts owed by group undertakings 199,001 151,429
Corporation tax - 1,491
Prepayments 473 498
213,971 163,001

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 2,041 1,705
Amounts owed to group undertakings 193,856 193,856
VAT 85,398 59,124
Accruals and deferred income - 5,014
281,295 259,699

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1 100 100